Prof. Jessica Zucman-Rossi
University Paris Descartes
Jessica Zucman-Rossi is Professor of Medicine at University Paris Descartes, within the depatment of Oncology at the European Hospital Geaorges Pompidou (AP-HP). She is the director of an INSERM laboratory “Functional Genomics of Solid Tumors”, with a focus on liver, mesothelial and renal tumors. Her team aims to develop basic genomic approaches based on human tumors analyses to identify new mechanisms of tumorigenesis and to transfer this knowledge into biomarkers that could be introduced in clinical care. In particular, the group was pioneer in the elucidation of the molecular classification of benign and malignant liver tumors. Currently, she is executive secretary of ILCA (International Liver Cancer Association) and she acts as co-Editor for Journal of Hepatology.
Prof. Adrian Reuben
Adrian Reuben is Professor of Medicine Emeritus’15 at the Medical University of South Carolina(MUSC), in Charleston SC, where, during 1993-2014, he directed the Liver Program he created.
Dr. Reuben graduated in Medicine, completed Residency and Gastroenterology Fellowship in London UK, before completing a scholarship at Yale. After a Yale faculty appointment (1981-1993), he moved to MUSC to establish the Liver Service and enhance the fledgling Liver Transplant (LT) program
His continues research on Acute Liver Failure (ALF), Coagulopathy in Liver Disease, Alcohol Biomarkers, Non-Invasive Investigation of Liver Disease and Drug Hepatotoxicity. He has considerable experience in LT, portal hypertension and he edited the May 2015 issue of Clinics in Liver Disease on Hepatocellular Carcinoma. He previously pursued laboratory-based investigation of biliary lipid secretion, and hepatic fibrogenesis. He has published 100+ peer-reviewed articles, editorials, case reports, and book chapters, as well as 44 essays in the acclaimed Landmarks in Hepatology series
He has presented at national and international meetings, taught in postgraduate courses and workshops, and lectured in three continents. His participation in American Association for the Study of Liver Diseases (AASLD) committees, includes the Ethics Committee of which he was also the Chair. He continues to lecture, perform and publish research, review manuscripts and grant applications, and write chapters and reviews. His interest in drug hepatotoxicity is exemplified by an original article in HEPATOLOGY, on Drug-Induced Liver ALF in the United States, chapters in hepatotoxicity textbooks and membership of the Hepatotoxicity Special Interest Group Steering Committee of the AASLD. He has also first-authored a recent 16-year overview of ALF experience by the US ALF Study Group, published in April 2016 in Annals of Internal Medicine. Finally, he has very close connections with Medicine in Israel, and with Israeli Hepatology in particular. He and his late wife spent a delightful 6-month sabbatical at Hadassah in 2011/2012, and he continues to visit Israel frequently, when he lectures and teaches at major Israeli medical centers. He also has reasonable conversational Hebrew
Prof Umberto Cillo, MD, FEBS
Professor of General Surgery
Director, Hepatobiliary and Liver Transplantation Unit
University of Padova, Italy
He is Professor of General Surgery at the Department of General Surgery, University of Padova since 2011 and Director of the Hepatobiliary and Liver Transplantation Unit, Department of General Surgery at the University of Padova since 2004.
He is President of the Italian Society of Organ Transplantation (SITO) and the Italian representative of the European Board of Surgery, section of Transplantation (UEMS).
Member of ESOT (European Society for Organ Transplantation) Council.
He will be President of the ESOT (European Society for Organ Transplantation) Congress in Milan, 2021.
Prof Cillo has performed as first surgeon/tutored over 3500 interventions of general surgery, over 1000 liver transplants, more than 140 cases of pediatric liver transplantation including split child-adult and adult-adult, living donor.
He performed the first auxiliary liver transplantation in Italy (2007) and the first liver autotransplantation (2011) in Italy.
Since 2004 more than 2300 liver resections, 1200 liver transplants and 3600 liver ablations have been performed in his Unit.
Prof Cillo is first author or co-author of 277 reviewed publications, 18 chapters and 4 monographs. I.F. (JCR) 1213,626 H-INDEX 40 (Scopus) 48 (Google Scholar)
Prof. Daniel Azoulay
Professor of Surgery, Dept HPB and Liver Transplant Surgery
Centre Hospitalo-Universitaire Hôpital Henri Mondor
Prof. Daniel Azoulay is one of the world’s leading surgeons in the field of complex liver surgeries and liver transplants.
Prof. Daniel Azoulay completed his medical studies at the University of Paris, and for 22 years he was a senior surgeon at the Hepatobiliary Center, founded by Professor Henry Bismuth at Paul Brousse Hospital. For seven years he has been Chief Department of Digestive, Hepato-Pancreato-Biliary and Liver Transplantation Surgery Hôpital Henri Mondor (University Hospital) – Assistance Publique-Hôpitaux de Paris.
To date, he has performed more than 1,500 liver transplants from dead and live donors and thousands of liver-pancreatic-biliary surgeries, some of which are highly complex.
Prof. Azoulay likes to teach and share his rich practical experience with medical students. He is a member of the European Society of Surgery and Liver Transplantation and has published more than 400 medical articles in the leading medical literature. He has also served as editor in major medical journals in the field of general surgery, liver and transplantation, including Annals of Surgery, British Journal of Surgery, and World Journal of Surgery.
His extensive experience in liver and pancreatic surgery includes in situ hypothermic perfusion of the Liver, surgical shunts, liver ablation in the front and split liver transplantation.